Volume 8 Issue 6
Nov.  2017
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2017  >  8(6): 435-439
Deng Feiwen, Chen Huanwei, Zhen Zuojun. Liver transplantation from donor liver of organ donation after citizen's death: a single center experience[J]. ORGAN TRANSPLANTATION, 2017, 8(6): 435-439. doi: 10.3969/j.issn.1674-7445.2017.06.005
Citation: Deng Feiwen, Chen Huanwei, Zhen Zuojun. Liver transplantation from donor liver of organ donation after citizen's death: a single center experience[J]. ORGAN TRANSPLANTATION, 2017, 8(6): 435-439. doi: 10.3969/j.issn.1674-7445.2017.06.005
shu

Liver transplantation from donor liver of organ donation after citizen's death: a single center experience

doi: 10.3969/j.issn.1674-7445.2017.06.005

  • Department of Liver and Pancreatic Surgery, the First People's Hospital of Foshan, Foshan 528000, China

More Information
  • Corresponding author: Chen Huanwei, Email: chwei_fsyyy@163.com
  • Received Date: 2017-08-17
    Available Online: 2021-01-19
  • Publish Date: 2017-11-15
    Abstract
  •   Objective  To evaluate the application value of donor liver from organ donation after citizen's death (organ donation) in clinical liver transplantation.  Methods  Clinical data of 75 pairs of donors and recipients undergoing liver transplantation from organ donation in the First People's Hospital of Foshan from October 2011 to December 2016 were retrospectively analyzed. The conditions of the donors were strictly evaluated. Clinical prognosis and the incidence of postoperative complications of the recipients were summarized.  Results  The 1-year and 3-year accumulated survival rates of 75 liver transplantation recipients were 88% and 78%. Four recipients died from the recurrence and metastasis of liver cancer, 1 case from graft-versus-host disease, 1 case from severe pulmonary infection, 1 case from recurrence of virus B hepatitis (hepatitis B) and liver failure, 1 case from postoperative multiple organ failure and 1 case from massive hemorrhage of the upper digestive tract. Thirteen recipients suffered from biliary tract stenosis. One case was mitigated spontaneously and 1 recipient was healed after percutaneous transhepatic biliary drainage (PTBD). Eleven cases were treated with endoscopic retrograde cholangiopancreatography (ERCP). Among them, 5 cases were healed, 2 recipients were switched to choledochojejunostomy and 4 cases were still monitored in clinical practice.  Conclusions  Liver transplantation from organ donation yields high clinical efficacy. Strict evaluation of donor conditions, standard perioperative management of the recipients, maintenance immunosuppressive therapy without adrenocortical hormone, timely and effective treatment of complications, regular postoperative follow-up are pivotal measures to guarantee the success of liver transplantation from organ donation and long-term survival of the recipients.

     

    • FullText(HTML)
  • loading
    • References(18)
  • [1]
    中华医学会器官移植学分会.中国心脏死亡器官捐献工作指南(第2版)[J].中华器官移植杂志, 2011, 32(12): 756-758. DOI: 10.3760/cma.j.issn.0254-1785. 2011.12.014.

    Branch of Organ Transplantation of Chinese Medical Association. Guide of donation after cardiac death in China(2nd ed)[J]. Chin J Organ Transplant, 2011, 32(12): 756-758. DOI: 10.3760/cma.j.issn.0254-1785.2011.12.014.
    [2]
    卫生部脑死亡判定标准起草小组.脑死亡判定标准(成人)(修订稿)[J].中国脑血管病杂志, 2009, 6(4): 220-224. DOI: 10.3969/j.issn.1672-5921.2009.04.014.

    The drafting group for brain death criteria of Ministry of Health of the People's Republic of China. Judgement standard of brain death (for adult) (revised edition)[J]. Chin J Cerebrovasc Dis, 2009, 6(4): 220-224. DOI: 10.3969/j.issn.1672-5921.2009.04.014.
    [3]
    Mancia C, Loustaud-Ratti V, Carrier P, et al. Controlled attenuation parameter and liver stiffness measurements for steatosis assessment in the liver transplant of brain dead donors[J]. Transplantation, 2015, 99(8): 1619-1624. DOI: 10.1097/TP.0000000000000652.
    [4]
    Flechtenmacher C, Schirmacher P, Schemmer P. Donor liver histology-a valuable tool in graft selection[J]. Langenbecks Arch Surg, 2015, 400(5): 551-557. DOI: 10.1007/s00423-015-1298-7.
    [5]
    Bertram S, Myland C, Swoboda S, et al. Liver steatosis in pre-transplant liver biopsies can be quantified rapidly and accurately by nuclear magnetic resonance analysis[J]. Virchows Arch, 2017, 470(2): 197-204. DOI: 10.1007/s00428-016-2047-1.
    [6]
    Zheng D, Guo Z, Schroder PM, et al. Accuracy of MR imaging and MR spectroscopy for detection and quantification of hepatic steatosis in living liver donors:a Meta-analysis[J]. Radiology, 2017, 282(1): 92-102. DOI: 10.1148/radiol.2016152571.
    [7]
    Huprikar S, Danziger-Isakov L, Ahn J, et al. Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management[J]. Am J Transplant, 2015, 15(5): 1162-1172. DOI: 10.1111/ajt.13187.
    [8]
    Loggi E, Conti F, Cucchetti A, et al. Liver grafts from hepatitis B surface antigen-positive donors: a review of the literature[J]. World J Gastroenterol, 2016, 22(35): 8010-8016. DOI: 10.3748/wjg.v22.i35.8010.
    [9]
    Olthoff KM, Kulik L, Samstein B, et al. Validation ofa current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors[J]. Liver Transpl, 2010, 16(8): 943-949. DOI: 10.1002/lt.22091.
    [10]
    Kang WH, Hwang S, Song GW, et al. Acute graft-vs-host disease after liver transplantation: experience ata high-volume liver transplantation center in Korea[J]. Transplant Proc, 2016, 48(10): 3368-3372. DOI: 10.1016/j.transproceed.2016.08.051.
    [11]
    Ascha MS, Ascha ML, Hanouneh IA. Management of immunosuppressant agents following liver transplantation: less is more[J]. World J Hepatol, 2016, 8(3): 148-161. DOI: 10.4254/wjh.v8.i3.148.
    [12]
    Yoo MC, Vanatta JM, Modanlou KA, et al. Steroid-free liver transplantation using rabbit antithymocyte globulin induction in 500 consecutive patients[J]. Transplantation, 2015, 99(6): 1231-1235. DOI: 10.1097/TP.0000000000000477.
    [13]
    Lerut JP, Pinheiro RS, Lai Q, et al. Is minimal, [almost] steroid-free immunosuppression a safe approach in adult liver transplantation? long-term outcome of a prospective, double blind, placebo-controlled, randomized, investigator-driven study[J]. Ann Surg, 2014, 260(5): 886-892. DOI: 10.1097/SLA.0000000000000969.
    [14]
    Sgourakis G, Dedemadi G. Corticosteroid-free immunosuppression in liver transplantation: an evidence-based review[J]. World J Gastroenterol, 2014, 20(31): 10703-10714. DOI: 10.3748/wjg.v20.i31.10703.
    [15]
    Wei Q, Xu X, Wang C, et al. Efficacy and safety ofa steroid-free immunosuppressive regimen after liver transplantation for hepatocellular carcinoma[J]. Gut Liver, 2016, 10(4): 604-610. DOI: 10.5009/gnl15017.
    [16]
    Fung J, Chan SC, Cheung C, et al. Oral nucleoside/nucleotide analogs without hepatitis B immune globulin after liver transplantation for hepatitis B[J]. Am J Gastroenterol, 2013, 108(6): 942-948. DOI: 10.1038/ajg.2013.111.
    [17]
    Memeo R, Piardi T, Sangiuolo F, et al. Management of biliary complications after liver transplantation[J]. World J Hepatol, 2015, 7(29): 2890-2895. DOI: 10.4254/wjh.v7.i29.2890.
    [18]
    Tringali A, Barbaro F, Pizzicannella M, et al. Endoscopic management with multiple plastic stents of anastomotic biliary stricture following liver transplantation: long-term results[J]. Endoscopy, 2016, 48(6): 546-551. DOI: 10.1055/s-0042-100277.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (90) PDF downloads(9) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return